
Venture Investors
Description
Venture Investors is a well-established venture capital firm based in Madison, Wisconsin, with a deep-rooted history in the Midwest's entrepreneurial ecosystem. Founded in 1982, it stands as one of the region's longest-standing venture capital firms, demonstrating decades of commitment to fostering innovation. The firm primarily focuses on providing seed and early-stage capital to promising technology companies, aiming to support their growth from nascent stages through significant development milestones.
The firm's investment strategy centers on identifying high-potential technology ventures, often in the Midwest, where they leverage their extensive network and regional expertise. Venture Investors typically deploys initial checks ranging from $500,000 to $2,000,000, providing crucial early-stage funding. Beyond the initial investment, they are prepared to make substantial follow-on investments, potentially committing up to $5,000,000 to $10,000,000 over the life of a portfolio company. This flexible approach allows them to support companies through multiple funding rounds as they scale.
With over $200 million in capital managed across several funds, Venture Investors has built a robust portfolio. Their commitment to the early-stage tech sector is evidenced by their investment in over 100 companies since their inception. This extensive track record includes a notable 26 exits, reflecting their ability to identify and nurture successful ventures. The firm emphasizes a collaborative partnership with its portfolio companies, offering strategic guidance and operational support to help them navigate the challenges of rapid growth and achieve market leadership. Their long tenure and consistent investment activity underscore their significant impact on the Midwest's technology landscape.
Investor Profile
Venture Investors has backed more than 106 startups, with 6 new investments in the last 12 months alone. The firm has led 55 rounds, about 52% of its total and boasts 22 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Biotechnology, Medical Device.
- Led 4 rounds in the past year.
- Typical check size: $500K – $2M.
Stage Focus
- Series A (36%)
- Series B (20%)
- Series Unknown (19%)
- Series C (11%)
- Seed (6%)
- Series D (3%)
- Post Ipo Equity (3%)
- Series E (1%)
- Convertible Note (1%)
- Series F (1%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Medical
- Therapeutics
- Software
- Pharmaceutical
- Hospital
- Life Science
- Manufacturing
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.